Pathogenesis and management of TRPV3-related Olmsted syndrome
Author Information
Author(s): Lu Antong, Li Kezhen, Huang Cong, Yu Bo, Zhong Weilong
Primary Institution: Peking University Shenzhen Hospital, Shenzhen, China
Hypothesis
The study reviews the genetics and pathogenesis of Olmsted syndrome, focusing on TRPV3 mutations and their implications for treatment.
Conclusion
The review highlights the pathogenic mechanisms of TRPV3 mutations in Olmsted syndrome and suggests potential therapeutic approaches.
Supporting Evidence
- Olmsted syndrome is characterized by severe skin conditions due to TRPV3 mutations.
- Recent studies suggest a genotype-phenotype correlation in TRPV3 mutations.
- Potential treatments include EGFR and mTOR inhibitors, which have shown promise in clinical cases.
Takeaway
Olmsted syndrome is a rare skin condition caused by mutations in a gene called TRPV3, which affects how skin cells grow and can lead to painful symptoms. Researchers are looking for better treatments to help people with this condition.
Methodology
The review is based on a literature search using PubMed to summarize reported cases and advancements related to Olmsted syndrome.
Limitations
The review may not cover all aspects of TRPV3-related Olmsted syndrome due to the complexity and rarity of the condition.
Participant Demographics
The condition affects both genders, with a male predisposition observed in approximately 63% of reported cases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website